🇺🇸 FDA
Pipeline program

[203Pb]Pb-PSV359

PSV359-001

Phase 2 small_molecule active

Quick answer

[203Pb]Pb-PSV359 for Pancreatic Ductal Adenocarcinoma is a Phase 2 program (small_molecule) at Perspective Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Perspective Therapeutics
Indication
Pancreatic Ductal Adenocarcinoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials